Quantitation of dopamine D2 receptor mRNA in a mesencephalic cell culture using a nonradioactive competitive reverse transcription polymerase chain reaction method

Journal of Neuroscience Methods

Volumn 82, Issue 2, 1998, Pages 187-194

  Gross, J ^a   Muller I ^a   Berndt, Ch ^a   Ungethum U ^a   Heldt, J ^a   Elizalde, M ^a   Peters, L E ^b   Andersson, K ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b InViTek GmbH   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell culture; D2 receptor; Dopamine; Polymerase chain reaction; Reverse transcription

Indexed keywords

COMPLEMENTARY RNA; DOPAMINE 2 RECEPTOR; MESSENGER RNA; PRIMER DNA;

ANIMAL CELL; ARTICLE; DOPAMINERGIC SYSTEM; FETUS; GENE EXPRESSION; MESENCEPHALON; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENETICS; IN SITU HYBRIDIZATION; KINETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RAT; WISTAR RAT;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; IN SITU HYBRIDIZATION; KINETICS; MESENCEPHALON; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RNA, MESSENGER;

EID: 0032129269     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(98)00048-X     Document Type: Article

References (23)

1. Alard P., Lantz O., Sebagh M., Calvo C.F., Weill D., Chavanel G., Senik A., Charpentier B. A versatile ELISA-PCR assay for mRNA quantitation from a few cells. BioTechniques. 15:1993;730-737.
2. Andreeva N., Ungethüm U., Heldt J., Marschhausen G., Altmann Th., Andersson K., Gross J. Elevated potassium enhances glutamate vulnerability of dopaminergic neurons developing in mesencephalic cell cultures. Exp Neurol. 137:1996;255-262.
3. Berndt Ch., Bebenroth M., Oehlschlegel K., Hiepe F., Schößler W. Quantitative polymerase chain reaction using a DNA hybridization assay based on surface-activated microplates. Anal Biochem. 225:1995;252-257.
4. 2R dopamine receptor cDNA. Nature. 336:1988;783-787.
5. Chan S.D., Dill K., Blomdahl J., Wada H.G. Nonisotopic quantitation of mRNA using a novel RNase protection assay: measurement of erbB-2 mRNA in tumor cell lines. Anal Biochem. 242:1996;214-220.
6. 2 dopamine receptor mRNA in rat corpus striatum. Dev Brain Res. 63:1991;95-104.
7. Collins M.L., Zayati J., Detmer J., Daly B., Kolberg J.A., Cha T.A., Irvine B.D., Tucker J., Urdea M.S. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem. 226:1995;120-129.
8. Ferre F, Marchese A, Pezzoli P, Griffin S, Buxton E, Boyer V. Quantitative PCR: an overview. In: Mullis KB, Ferre F, Gibbs RA, editors. The Polymerase Chain Reaction. Boston: Birkhäuser, 1994:67-88.
9. Giros B., Sokoloff P., Martres M.P., Riou J.F., Emorine L.J., Schwartz J.C. Alternative splicing directs the expression of the two D2 dopamine receptor isoforms. Nature. 342:1989;923-926.
10. Hahn M., Dörsam V., Friedhoff P., Fritz A., Pingoud A. Quantitative polymerase chain reaction with enzyme-linked immunosorbent assay detection of selectively digested amplified sample and control DNA. Anal Biochem. 229:1995;236-248.
11. 2 receptor messenger RNAs are differentially expressed in limbic-and motor-related subpopulations of human mesencephalic neurons. Neuroscience. 63:1994;357-362.
12. Jean L., Lyoumi S., Salier J.-P. Quantitative reverse transcriptase polymerase chain reaction of eukaryotic mRNA with the prokaryotic chloramphenicol acetyl transferase RNA as a universal, internal standard. Anal Biochem. 234:1996;224-226.
13. Lee P.J., Washer L.L., Law D.J., Boland C.R., Horon I.L., Feinberg A.P. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci USA. 93:1996;10366-10370.
14. 2 receptor messenger RNAs during development. Dev Brain Res. 59:1991;249-251.
15. 2 dopamine receptor mRNA levels in striatal neurones in primary culture. J Rec Res. 13:1993;313-328.
16. Murray A.M., Weihmueller F.B., Marshall J.F., Hurtig H.I., Gottleib G.L., Joyce J.N. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol. 37:1995;300-312.
17. O'Driscoll L., Daly C., Saleh M., Clynes M. The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells. Cytotechnology. 12:1993;289-314.
18. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62:1994;65-85.
19. 2 receptor activation does not affect survival and differentiation of cultured dopaminergic neurons: morphological and neurochemical observations. J Neurochem. 60:1993;83-92.
20. Vogelstein B., Gillepse D. Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci USA. 76:1979;615-619.
21. Wang A.M., Doyle M.V., Mark D.F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA. 86:1989;9717-9721.
22. Zenilman M.E., Graham W., Tanner K., Shuldiner A.R. Competitive reverse-transcriptase polymerase chain reaction without an artificial internal standard. Anal Biochem. 224:1995;339-346.
23. Zhang H., Lee T.H., Ellinwood E.H. Jr. The progressive changes of neuronal activities of the nigral dopaminergic neurons upon withdrawal from continuous infusion of cocaine. Brain Res. 594:1992;315-318.